Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 19, 2022, titled "Glenmark Pharmaceuticals receives ANDA approval for Nicardipine HydrochlorideCapsules, 20 mg and 30 mg".
Press Release Dec 19 2022
Filed with NSE ·
6ix hasn’t read this filing yet.
Glenmark Pharmaceuticals Limited on 6ix
Earlier from Glenmark Pharmaceuticals
- Press Release Nov 22 2022
- Press Release Nov 02 2022
- Press Release Oct 31 2022
- Press Release Oct 20 2022
- Press Release Oct 06 2022
Later from Glenmark Pharmaceuticals
- Press Release Dec 21 2022
- Glenmark Pharmaceuticals Limited Press Release Jan 10 2023
- Press Release Jan 17 2023
- Glenmark Pharmaceuticals Limited Press Release Jan 23 2023
- Glenmark Pharmaceuticals Limited Press Release Feb 17 2023
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals